Reviewed clinical summary · Source-linked · Educational use only

Cyperus rotundus Extract with Piperine for Weight Loss: Double-Blind Placebo-Controlled Trial

Clinical Bottom Line

A 90-day manufacturer-funded RCT finds Cyperus rotundus extract with piperine, added to diet and exercise, reduces weight and central adiposity and improves lipids in obese adults. PICO summary and commentary.

Summary: In a 90-day placebo-controlled trial in obese adults, a Cyperus rotundus extract with piperine, added to diet and exercise, reduced body weight, BMI, and waist and hip circumference, and improved lipid profile and ApoB-100, with no reported adverse events.

PICO Summary

ElementDetail
Population96 obese adults; 90-day randomised, double-blind, placebo-controlled trial, India (industry-funded by the extract manufacturer).
Intervention500 mg Cyperus rotundus extract (standardised to 6–8% stilbenes) plus 5 mg piperine, twice daily, with prescribed diet and exercise.
ComparisonMatching placebo twice daily with the same diet and exercise guidance.
OutcomeThe extract group had significantly greater reductions in body weight, BMI, and waist and hip circumference than placebo, with improvements in serum lipid profile and Apolipoprotein B-100. No adverse events were reported and laboratory parameters stayed within normal ranges.
RCT Medicine (Baltimore) · 2025

Cyperus rotundus + piperine for weight loss

RCT · obese adults · 90 days

Trial design
96 obese adults Enrolled & assessed RANDOMISED 1:1 CRE + piperine 500mg CRE + 5mg piperine n = 48 Placebo Microcrystalline placebo n = 48 Body weight change at 90 days
Change from baseline — both arms
% body weight Baseline Day 90 −7.1% vs −2.6% CRE + piperine Placebo
Weight
−7.1%
CREP vs −2.6%
BMI
−6.9%
vs −2.7% placebo
≥5% loss
89.5%
vs 12.5% placebo
Triglycerides
−35.5
mg/dL (p=.006)
⬡ Bottom Line

Over 90 days, CRE with piperine added to diet and exercise cut body weight by 7.1% versus 2.6% on placebo, with 89.5% of the extract group reaching clinically meaningful 5% loss. The result is promising but manufacturer-funded and short-term, so it needs independent replication.

Expert Commentary

This is a reasonably designed supplement trial with an appropriate use case, since both arms received diet and exercise and the extract was tested as an adjunct rather than a replacement, which is the honest way to study a weight-management supplement. The signal is coherent, with reductions in weight and central adiposity plus a favourable shift in lipids and ApoB, and the stilbene chemistry, structurally related to resveratrol, gives a plausible metabolic rationale. The caveat that should travel prominently with these results is the sponsorship: the trial was funded and conducted by the extract’s manufacturer, which is a recognised source of bias in supplement research and warrants independent replication before confidence. Other limits include a 90-day window that cannot establish durability or long-term safety, a modest sample, unverified diet and exercise adherence, and a proprietary formulation that may not match commercial products of variable quality. Piperine can also alter cytochrome P450 drug metabolism. Can I use this with my patients? Cautiously and non-committally. For a patient determined to try a natural adjunct alongside genuine lifestyle change, this is a low-risk option over the short term, but I would be candid about the industry funding and the lack of independent, long-term data, and would keep proven approaches central.

References

Majeed A, Majeed S, Devarajan TV, et al. Efficacy and safety of Cyperus rotundus extract on weight management in obese individuals: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2025;104(47):e45666. doi:10.1097/MD.0000000000045666

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.